ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 125 filers reported holding ARBUTUS BIOPHARMA CORP in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $68,508 | -17.6% | 22,171 | -31.2% | 0.01% | -9.1% |
| Q1 2024 | $83,161 | +71.5% | 32,233 | +66.1% | 0.01% | +22.2% |
| Q4 2023 | $48,500 | +456.1% | 19,400 | +351.6% | 0.01% | +200.0% |
| Q3 2023 | $8,721 | +74.2% | 4,296 | +97.3% | 0.00% | +50.0% |
| Q2 2023 | $5,007 | -22.1% | 2,177 | +2.7% | 0.00% | 0.0% |
| Q1 2023 | $6,424 | +73.4% | 2,120 | +33.3% | 0.00% | +100.0% |
| Q4 2022 | $3,705 | +23.5% | 1,590 | +13.2% | 0.00% | 0.0% |
| Q3 2022 | $3,000 | – | 1,404 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| QVT Financial LP | 16,013,540 | $39,233,000 | 1.19% |
| ARMISTICE CAPITAL, LLC | 1,940,000 | $4,753,000 | 1.12% |
| DAFNA Capital Management LLC | 234,000 | $573,000 | 0.50% |
| Alpha Wave Global, LP | 1,655,162 | $4,055,000 | 0.43% |
| Telemetry Investments, L.L.C. | 150,000 | $368,000 | 0.21% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 5,294,945 | $12,972,000 | 0.18% |
| SABBY MANAGEMENT, LLC | 792,617 | $1,942,000 | 0.11% |
| K2 PRINCIPAL FUND, L.P. | 443,887 | $1,088,000 | 0.10% |
| Anson Funds Management LP | 105,085 | $257,000 | 0.08% |
| DIALECTIC CAPITAL MANAGEMENT, LP | 25,000 | $61,000 | 0.03% |